E-mail a Wiley Online Library Link

Grace K. Dy, Shauna L. Hillman, Kendrith M. Rowland Jr, Julian R. Molina, Preston D. Steen, Donald B. Wender, Suresh Nair, Sumithra Mandrekar, Steven E. Schild and Alex A. Adjei A front-line window of opportunity phase 2 study of sorafenib in patients with advanced nonsmall cell lung cancer Cancer 116

Version of Record online: 31 AUG 2010 | DOI: 10.1002/cncr.25448

Sorafenib is not effective as front-line therapy in the general unselected nonsmall cell lung cancer population.

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field